# Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)

> **NCT00307229** · PHASE1 · COMPLETED · sponsor: **Ontario Clinical Oncology Group (OCOG)** · enrollment: 8 (actual)

## Conditions studied

- Metastatic Breast Cancer
- Recurrent Breast Cancer

## Interventions

- **BIOLOGICAL:** adenoviral vector encoding rat Her-2/neu

## Key facts

- **NCT ID:** NCT00307229
- **Lead sponsor:** Ontario Clinical Oncology Group (OCOG)
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2009-07
- **Final completion:** 2012-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2012-06-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307229, "Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00307229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*